Growth Factors and Myometrium: Biological Effects in Uterine Fibroid and Possible Clinical Implications

Overview

Journal Hum Reprod Update

Specialty Reproductive Medicine

Date 2011 Jul 27

PMID 21788281

Citations 73

Authors

Pasquapina Ciarmela

Md Soriful Islam

Fernando M Reis

Peter C Gray

Enrrico Bloise

Felice Petraglia

Wylie Vale

Mario Castellucci

Affiliations

Soon will be listed here.

Abstract

Background: Growth factors are proteins secreted by a number of cell types that are capable of modulating cellular growth, proliferation and cellular differentiation. It is well accepted that uterine cellular events such as proliferation and differentiation are regulated by sex steroids and their actions in target tissues are mediated by local production of growth factors acting through paracrine and/or autocrine mechanisms. Myometrial mass is ultimately modified in pregnancy as well as in tumour conditions such as leiomyoma and leiomyosarcoma. Leiomyomas, also known as fibroids, are benign tumours of the uterus, considered to be one of the most frequent causes of infertility in reproductive years in women.

Methods: For this review, we searched the database MEDLINE and Google Scholar for articles with content related to growth factors acting on myometrium; the findings are hereby reviewed and discussed.

Results: Different growth factors such as epidermal growth factor (EGF), transforming growth factor-α (TGF-α), heparin-binding EGF (HB-EGF), acidic fibroblast growth factor (aFGF), basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF) and TGF-β perform actions in myometrium and in leiomyomas. In addition to these growth factors, activin and myostatin have been recently identified in myometrium and leiomyoma.

Conclusions: Growth factors play an important role in the mechanisms involved in myometrial patho-physiology.

Citing Articles

The influence of uterine leiomyomatosis on the onset of psoriasis: a nationwide population-based study of 2.5 million Korean females.

Kim Y, Kim H, Doh J, Han K, Lee J BMC Womens Health. 2025; 25(1):50.

PMID: 39910492 PMC: 11796066. DOI: 10.1186/s12905-024-03529-7.

The Interplay of Uterine Health and Obesity: A Comprehensive Review.

Sisljagic D, Blazetic S, Heffer M, Vranjes Delac M, Muller A Biomedicines. 2025; 12(12.

PMID: 39767708 PMC: 11673887. DOI: 10.3390/biomedicines12122801.

Biomimicking trilayer scaffolds with controlled estradiol release for uterine tissue regeneration.

Chen S, Li J, Zheng L, Huang J, Wang M Exploration (Beijing). 2024; 4(5):20230141.

PMID: 39439492 PMC: 11491300. DOI: 10.1002/EXP.20230141.

mTOR activity paces human blastocyst stage developmental progression.

Iyer D, Khoei H, van der Weijden V, Kagawa H, Pradhan S, Novatchkova M Cell. 2024; 187(23):6566-6583.e22.

PMID: 39332412 PMC: 7617234. DOI: 10.1016/j.cell.2024.08.048.

The role of VEGF and TGF-β blood levels for fibroid shrinkage, menorrhagia score, and quality of life improvement after uterine artery embolization for uterine fibroids: a study protocol.

Aimagambetova G, Bapayeva G, Ukybassova T, Zemlyanskiy V, Gusmanov A, Terzic M Front Med (Lausanne). 2024; 11:1382822.

PMID: 39165371 PMC: 11334076. DOI: 10.3389/fmed.2024.1382822.

References

Maruo T, Matsuo H, Shimomura Y, Kurachi O, Gao Z, Nakago S . Effects of progesterone on growth factor expression in human uterine leiomyoma. Steroids. 2003; 68(10-13):817-24. DOI: 10.1016/j.steroids.2003.08.017. View

Moore A, Yu L, Swartz C, Zheng X, Wang L, Castro L . Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type I production, and activate RTKs and TGF beta receptor signaling in coculture. Cell Commun Signal. 2010; 8:10. PMC: 2897788. DOI: 10.1186/1478-811X-8-10. View

Nowak R . Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors. Environ Health Perspect. 2000; 108 Suppl 5:849-53. DOI: 10.1289/ehp.00108s5849. View

Burroughs K, Fuchs-Young R, Davis B, Walker C . Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol Reprod. 2000; 63(5):1322-30. DOI: 10.1095/biolreprod63.5.1322. View

Lei J, Jiang A, Pei D . Identification and characterization of a new splicing variant of vascular endothelial growth factor: VEGF183. Biochim Biophys Acta. 1999; 1443(3):400-6. DOI: 10.1016/s0167-4781(98)00240-1. View

Shushan A, Rojansky N, Laufer N, Klein B, Shlomai Z, Levitzki R . The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth. Hum Reprod. 2004; 19(9):1957-67. DOI: 10.1093/humrep/deh355. View

McPherron A, Lawler A, Lee S . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997; 387(6628):83-90. DOI: 10.1038/387083a0. View

Grobet L, Martin L, Poncelet D, Pirottin D, Brouwers B, Riquet J . A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet. 1997; 17(1):71-4. DOI: 10.1038/ng0997-71. View

Houston K, Copland J, Moorman V, Walker C, Davis B . Uterine leiomyomas express myometrial contractile-associated proteins involved in pregnancy-related hormone signaling. J Soc Gynecol Investig. 2003; 10(1):11-20. View

10.

Barbarisi A, Petillo O, Di Lieto A, Melone M, Margarucci S, Cannas M . 17-beta estradiol elicits an autocrine leiomyoma cell proliferation: evidence for a stimulation of protein kinase-dependent pathway. J Cell Physiol. 2001; 186(3):414-24. DOI: 10.1002/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO;2-E. View

11.

Harrison C, Gray P, Fischer W, Donaldson C, Choe S, Vale W . An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors. J Biol Chem. 2004; 279(27):28036-44. DOI: 10.1074/jbc.M402782200. View

12.

Gray P, Shani G, Aung K, Kelber J, Vale W . Cripto binds transforming growth factor beta (TGF-beta) and inhibits TGF-beta signaling. Mol Cell Biol. 2006; 26(24):9268-78. PMC: 1698529. DOI: 10.1128/MCB.01168-06. View

13.

Stewart E . Uterine fibroids. Lancet. 2001; 357(9252):293-8. DOI: 10.1016/S0140-6736(00)03622-9. View

14.

Malik M, Norian J, McCarthy-Keith D, Britten J, Catherino W . Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med. 2010; 28(3):169-79. DOI: 10.1055/s-0030-1251475. View

15.

Newbold R, Moore A, Dixon D . Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES). Toxicol Pathol. 2002; 30(5):611-6. DOI: 10.1080/01926230290105839. View

16.

Matsuo H, Kurachi O, Shimomura Y, Samoto T, Maruo T . Molecular bases for the actions of ovarian sex steroids in the regulation of proliferation and apoptosis of human uterine leiomyoma. Oncology. 1999; 57 Suppl 2:49-58. DOI: 10.1159/000055275. View

17.

Ding L, Xu J, Luo X, Chegini N . Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression.... J Clin Endocrinol Metab. 2004; 89(11):5549-57. DOI: 10.1210/jc.2004-0161. View

18.

Massague J, Attisano L, Wrana J . The TGF-beta family and its composite receptors. Trends Cell Biol. 1994; 4(5):172-8. DOI: 10.1016/0962-8924(94)90202-x. View

19.

Muenster U, Harrison C, Donaldson C, Vale W, Fischer W . An activin-A/C chimera exhibits activin and myostatin antagonistic properties. J Biol Chem. 2005; 280(44):36626-32. DOI: 10.1074/jbc.M507236200. View

20.

Rider V, Carlone D, Foster R . Oestrogen and progesterone control basic fibroblast growth factor mRNA in the rat uterus. J Endocrinol. 1997; 154(1):75-84. DOI: 10.1677/joe.0.1540075. View